Search Results

There are 2913419 results for: content related to: Metabolomics and the search for biomarkers in Parkinson's disease

  1. 3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis

    Movement Disorders

    Volume 28, Issue 12, October 2013, Pages: 1653–1660, Peter A. LeWitt, Jia Li, Mei Lu, Thomas G. Beach, Charles H. Adler, Lining Guo and the Arizona Parkinson's Disease Consortium

    Version of Record online : 19 JUL 2013, DOI: 10.1002/mds.25555

  2. The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations

    Movement Disorders

    Volume 31, Issue 8, August 2016, Pages: 1080–1094, Raul Martínez-Fernández, Emmanuelle Schmitt, Pablo Martinez-Martin and Paul Krack

    Version of Record online : 19 JUL 2016, DOI: 10.1002/mds.26731

  3. You have full text access to this OnlineOpen article
    Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

    Movement Disorders

    Jennifer L. Whitwell, Günter U. Höglinger, Angelo Antonini, Yvette Bordelon, Adam L. Boxer, Carlo Colosimo, Thilo van Eimeren, Lawrence I. Golbe, Jan Kassubek, Carolin Kurz, Irene Litvan, Alexander Pantelyat, Gil Rabinovici, Gesine Respondek, Axel Rominger, James B. Rowe, Maria Stamelou, Keith A. Josephs and for the Movement Disorder Society-endorsed PSP Study Group

    Version of Record online : 13 MAY 2017, DOI: 10.1002/mds.27038

  4. The focal dystonias: Current views and challenges for future research

    Movement Disorders

    Volume 28, Issue 7, 15 June 2013, Pages: 926–943, H. A. Jinnah, Alfredo Berardelli, Cynthia Comella, Giovanni DeFazio, Mahlon R. DeLong, Stewart Factor, Wendy R. Galpern, Mark Hallett, Christy L. Ludlow, Joel S. Perlmutter, Ami R. Rosen and for the Dystonia Coalition Investigators

    Version of Record online : 25 JUL 2013, DOI: 10.1002/mds.25567

  5. “Atypical” atypical parkinsonism: New genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy—A diagnostic guide

    Movement Disorders

    Volume 28, Issue 9, August 2013, Pages: 1184–1199, Maria Stamelou, Niall P. Quinn and Kailash P. Bhatia

    Version of Record online : 29 MAY 2013, DOI: 10.1002/mds.25509

  6. Neuropathology of multiple system atrophy: New thoughts about pathogenesis

    Movement Disorders

    Volume 29, Issue 14, December 2014, Pages: 1720–1741, Kurt A. Jellinger

    Version of Record online : 9 OCT 2014, DOI: 10.1002/mds.26052

  7. Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 848–860, Steffen Halbgebauer, Patrick Öckl, Katharina Wirth, Petra Steinacker and Markus Otto

    Version of Record online : 2 MAY 2016, DOI: 10.1002/mds.26635

  8. Norepinephrine deficiency in Parkinson's disease: The case for noradrenergic enhancement

    Movement Disorders

    Volume 29, Issue 14, December 2014, Pages: 1710–1719, Alberto J. Espay, Peter A. LeWitt and Horacio Kaufmann

    Version of Record online : 9 OCT 2014, DOI: 10.1002/mds.26048

  9. You have full text access to this OnlineOpen article
    metabolic profiling of Parkinson's disease and mild cognitive impairment

    Movement Disorders

    Florence Burté, David Houghton, Hannah Lowes, Angela Pyle, Sarah Nesbitt, Alison Yarnall, Patrick Yu-Wai-Man, David J. Burn, Mauro Santibanez-Koref and Gavin Hudson

    Version of Record online : 10 APR 2017, DOI: 10.1002/mds.26992

  10. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 861–881, Manuel Delgado-Alvarado, Belén Gago, Irene Navalpotro-Gomez, Haritz Jiménez-Urbieta and María C. Rodriguez-Oroz

    Version of Record online : 19 MAY 2016, DOI: 10.1002/mds.26662

  11. Biomarkers for trials of neuroprotection in Parkinson's disease

    Movement Disorders

    Volume 28, Issue 1, January 2013, Pages: 71–85, Pankaj A. Agarwal and A. Jon Stoessl

    Version of Record online : 24 AUG 2012, DOI: 10.1002/mds.25065

  12. Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 64–72, Peter A. LeWitt

    Version of Record online : 1 DEC 2014, DOI: 10.1002/mds.26082

  13. You have free access to this content
    Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease

    Movement Disorders

    Volume 32, Issue 3, March 2017, Pages: 346–363, Maria Pia Giannoccaro, Chiara La Morgia, Giovanni Rizzo and Valerio Carelli

    Version of Record online : 2 MAR 2017, DOI: 10.1002/mds.26966

  14. Animal models of Huntington's disease for translation to the clinic: Best practices

    Movement Disorders

    Volume 29, Issue 11, 15 September 2014, Pages: 1375–1390, Liliana Menalled and Daniela Brunner

    Version of Record online : 12 SEP 2014, DOI: 10.1002/mds.26006

  15. Volumetric correlates of cognitive functioning in nondemented patients with Parkinson's disease

    Movement Disorders

    Volume 29, Issue 3, March 2014, Pages: 360–367, J. Vincent Filoteo, Jason D. Reed, Irene Litvan and Deborah L. Harrington

    Version of Record online : 3 SEP 2013, DOI: 10.1002/mds.25633

  16. Objective biomarkers of balance and gait for Parkinson's disease using body-worn sensors

    Movement Disorders

    Volume 28, Issue 11, 15 September 2013, Pages: 1544–1551, Fay B. Horak and Martina Mancini

    Version of Record online : 16 OCT 2013, DOI: 10.1002/mds.25684

  17. Medical treatment of dystonia

    Movement Disorders

    Volume 28, Issue 7, 15 June 2013, Pages: 1001–1012, Joseph Jankovic

    Version of Record online : 25 JUL 2013, DOI: 10.1002/mds.25552

  18. Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association?

    Movement Disorders

    Volume 31, Issue 7, July 2016, Pages: 937–946, Claire McDonald, Julia L. Newton and David J. Burn

    Version of Record online : 19 APR 2016, DOI: 10.1002/mds.26632

  19. Deep brain stimulation for gait and postural symptoms in Parkinson's disease

    Movement Disorders

    Volume 28, Issue 11, 15 September 2013, Pages: 1609–1615, Monika Pötter-Nerger and Jens Volkmann

    Version of Record online : 16 OCT 2013, DOI: 10.1002/mds.25677

  20. Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder

    Movement Disorders

    Volume 28, Issue 9, August 2013, Pages: 1263–1270, Pablo R. Moya, Jens R. Wendland, Liza M. Rubenstein, Kiara R. Timpano, Gary A. Heiman, Jay A. Tischfield, Robert A. King, Anne M. Andrews, Samanda Ramamoorthy, Francis J. McMahon and Dennis L. Murphy

    Version of Record online : 29 APR 2013, DOI: 10.1002/mds.25460